Scientific Articles

Jun 02, 2025

Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis

May 27, 2025

Biomarkers in transthyretin amyloidosis. Present and futureBiomarcadores en amiloidosis por transtirretina. Presente y futuro

May 13, 2025

Clinical and Biochemical Characterization of Hereditary ATTR Amyloidosis Caused by a Novel Transthyretin Variant V121A (p.V141A)

May 13, 2025

Diagnosis and Management of Mixed Phenotype Hereditary Transthyretin Amyloidosis: A Case-Based, Canadian Perspective

May 05, 2025

Current Landscape of Therapies for Transthyretin Amyloid Cardiomyopathy

Apr 29, 2025

Reliability and validity of the Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire impact scales

Apr 28, 2025

Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China

Apr 16, 2025

More players in the treatment of transthyretin amyloidosis? The HELIOS-B study

Apr 09, 2025

Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up

INTRODUCTIONTransthyretin amyloid cardiomyopathy (ATTR-CM) is a chronic disease caused by transthyretin (TTR) tetramer destabilization and subsequent TTR amyloid…

Apr 02, 2025

Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry

AbstractObjectives: Proteinuria, amyloidosis, and kidney failure are the main long-term renal complications of familial Mediterranean fever (FMF). This study…

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Subscribe to